Navigation Links
New Seminar Series from Activator Methods Teaches Doctors a Unique Approach to Improving Nation's Chiropractic Care: Focus on the Patients
Date:9/19/2007

PHOENIX, Sept. 19 /PRNewswire/ -- Activator Methods International (http://www.activator.com), pioneer in chiropractic instrument manufacturing and technique training for 40 years, has formed an alliance with three leading chiropractic companies to create the Activator Advantage seminar series. The series, designed to help doctors improve the level of care they provide patients, kicked off September 15th in St. Louis.

"What's new about the Activator Advantage seminars is that we are focusing first on the patient," says Dr. Arlan Fuhr CEO, co-founder and inventor of the Activator Method. "In the past, companies have placed a lot of focus on managing the practice. At times this has resulted in less than satisfactory service to patients. Our new Activator Advantage seminars teach doctors how to ethically improve patient satisfaction and outcomes through technique, documentation, technology and management solutions."

The Activator Advantage, formed this year, includes contributions from DC Mentors, Inc., (http://www.dcmentors.com), MyoVision, (http://www.myovision.com) and Future Health, Inc., (http://www.futurehealthsoftware.com). Together the three companies along with Activator Methods make up the building blocks of the Activator Advantage: Technique, Technology, Documentation and Outcomes. According to Dr. Fuhr, the alliance works because it brings the right disciplines together at the right time in the right way. "We've found in our own pilot clinics that when you put all of these systems together it clicks for the patient and the doctor."

DC Mentors, headed by Dr. Frank Sovinsky, offers a patient care system that honors the intelligence of the patient. Through his program chiropractors will be able to identify the emotion
'/>"/>

SOURCE Activator Methods International, Ltd.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Seminar On US Medical Licencing Exam For Docs And Medicos
2. Maverick Gay Ex-governor Turns a New Leaf - Accepted at the Episcopalian Seminary
3. Maverick Gay Ex-governor Turns a New Leaf - Accepted at the Episcopalian Seminary
4. Kerala Institute to Hold International Seminar on Drug Discovery
5. Harmison Ruled Out Off Test Series Due to Hernia
6. Adopting Easier Methods To Screen Insulin Resistance
7. New methods to prevent injury of patients
8. Methods to have a flat stomach
9. Bioengineering production strains - Microbia develops new methods
10. Easier Methods Required to Screen Insulin Resistance
11. Easier Methods Required to Screen Insulin Resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2010)... Taxes, Other Tobacco Prevention Initiatives , ... , , ... ... ... WASHINGTON , March 18 Kids in New Jersey will take center stage in the fight against tobacco on March ...
(Date:3/18/2010)... ... , , ... ... ... New Hampshire will take center stage in the fight against tobacco on March 24 as they join thousands of young people nationwide ...
(Date:3/18/2010)... President and CEO, Legacy(SM) , ... , , ... ... WASHINGTON , March ... ...
(Date:3/18/2010)... of U.S. medical students choosing internal medicine residencies ... significantly impact the shortage of primary care physicians. ... Program report, 2,722 U.S. seniors at medical schools ... 3.4 percent increase from 2,632 in 2009. The ... (2,660), 2007 (2,680), and 2006 (2,668). In comparison, ...
(Date:3/18/2010)... In its 21-year history, under the ... leaders, SRLA has trained more than 40,000 teenagers from ... area to complete the 26.2 mile Los Angeles Marathon. ... volunteer leaders will again participate in the LA Marathon. ... SRLA,s mission is to challenge at-risk secondary students to ...
Breaking Medicine News(10 mins):Health News:New Jersey Kids 'Kick Butts' on March 24 2Health News:New Jersey Kids 'Kick Butts' on March 24 3Health News:New Jersey Kids 'Kick Butts' on March 24 4Health News:New Jersey Kids 'Kick Butts' on March 24 5Health News:New Hampshire Kids 'Kick Butts' on March 24 2Health News:New Hampshire Kids 'Kick Butts' on March 24 3Health News:New Hampshire Kids 'Kick Butts' on March 24 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 2Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 3Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 4Health News:Food and Drug Administration Issues Final Rule Regarding Sale, Distribution, and Use of Cigarettes and Smokeless Tobacco 5Health News:Residency match results not encouraging for adults needing primary care 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 3
... French . , Montreal, April 14 2009 ... rule seems to apply to most diseases except HIV-AIDS, which ... called "CD4+" cells have disappeared. The results of a North ... of the Research Institute of the MUHC, run contrary to ...
... offer added flavors, antioxidants and nutritional benefits; Packaging now ... new wave of excitement to the enhanced water category, ... a low-calorie, nutrient enhanced water beverage designed to help ... 10 calories per serving(1), Propel is available ...
... Warns of Effects From Bleeding to Drug Interactions NEW ... or "herbal" are virtually synonymous with safety and purity. ... mistakenly believed to be free of significant risks. A ... warns that more than 40% of plastic surgery patients ...
... SAN FRANCISCO, April 14 Deloitte today released a ... of follow-on biologics, that explores the debate on ... biologics (FOBs), drugs that are envisioned as the biotech ... that have recently been introduced in Congress, both based ...
... guide to showcase Malaysia,s world-class medical facilities , ... ... of Private Hospitals of Malaysia (APHM) jointly announce the launch of ... for international distribution. The Malaysia Edition will be formally launched on ...
... sole marketing exclusivityPITTSBURGH, April 14 Mylan Inc. (Nasdaq: ... and its subsidiary Mylan Pharmaceuticals Inc. have been sued ... of an Abbreviated New Drug Application (ANDA) with the ... 150 mg and 500 mg, the generic version of ...
Other Medicine News:Health News:Treating HIV earlier to decrease the risk of death 2Health News:Propel Unveils New Enhanced Experience 2Health News:Propel Unveils New Enhanced Experience 3Health News:Are Herbal Supplements Putting Aesthetic Surgery Patients at Risk? 2Health News:Are Herbal Supplements Putting Aesthetic Surgery Patients at Risk? 3Health News:Are Herbal Supplements Putting Aesthetic Surgery Patients at Risk? 4Health News:Avoiding No Man's Land: New Deloitte Study on Follow-on Biologics Investigates Proposed Legislation and Possible Unintended Consequences 2Health News:Avoiding No Man's Land: New Deloitte Study on Follow-on Biologics Investigates Proposed Legislation and Possible Unintended Consequences 3Health News:Avoiding No Man's Land: New Deloitte Study on Follow-on Biologics Investigates Proposed Legislation and Possible Unintended Consequences 4Health News:Patients Beyond Borders Malaysia Edition to Launch in July 2Health News:Patients Beyond Borders Malaysia Edition to Launch in July 3Health News:Mylan Confirms First-to-File Patent Challenge Relating to Xeloda(R) Cancer Treatment 2
(Date:3/18/2010)... March 18 Poniard Pharmaceuticals, Inc. ... innovative oncology therapies, today announced that the U.S. Patent ... the composition of matter patent for picoplatin as RE41209, ... 2010 . The reissue was applied for May ... , the USPTO released the "Issue Notification" for the ...
(Date:3/18/2010)... , March 18 ... Chief Executive Officer, Pfizer, was elected board ... of America (PhRMA) today at the trade ... Chief Executive Officer Christopher Viehbacher ... Directors, and John C. Lechleiter , ...
(Date:3/18/2010)... results in too much ammonia in the blood. , ... , , ... ... (Logo: ... ...
Breaking Medicine Technology:U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 2U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 3U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 4U.S. Patent and Trademark Office Grants Reissue Patent on Picoplatin Composition of Matter 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 2Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 3Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 4Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 5Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 6Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 7Pfizer's Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts 8FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 2FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 3FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 4FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels 5Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 1Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 2Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 61897 3Exposure to lead tobacco smoke raises risk of ADHD 10856 1Exposure to lead tobacco smoke raises risk of ADHD 10856 2Measuring and modeling blood flow in malaria 61892 1Measuring and modeling blood flow in malaria 61892 2
... Pharmacopeia Elects to Expand Study to Include 1,000 mg ... PCOP ), an innovator in the discovery and development ... initial results,from the Company,s Phase 1 multiple ascending dose ... no safety or tolerability,issues were observed with any of ...
... Sept. 12 Alfacell Corporation,(Nasdaq: ACEL ) ... events,(patient deaths) have occurred in the Phase IIIb ... treatment of patients with unresectable,malignant mesothelioma. The number ... that total events in the study had reached ...
Other Medicine Technology:Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA) 2Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA) 3Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA) 4Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 2Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 3
The Natural Selection family of specialty allografts are spinal allograft devices to eliminate the need for painful autograft harvesting....
... VG2 PLIF Allograft is comprised ... surrounding a cancellous center. The cortical ... support. The cancellous bone provides a ... osteoconductive environment. Superior and inferior surface ...
Williams Micro Discectomy Instruments are designed to be used in the microsurgical treatment of herniated disks....
Meyerding Laminectomy Retractors, self-retaining....
Medicine Products: